Studying the microbiome: Clinical trial distribution indicates emphasis on holistic vs mechanistic approaches

The microbiome is a term that has captivated the attention and interest of both industry professionals and consumers alike. However, it is safe to say that to date, much of our understanding of the mechanisms by which this phenomenon acts are limited at best. Researchers – operating at the in vit...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Prevailing theory on Alzheimer's disease (AD) is challenged by new research finding

News Commentary | June 29, 2021

Biogen's recent FDA approval for its AD drug continues to trigger controversy, as we have discussed here and here. Part of the reason is that the drug is based on the "amyloid hypothesis," which posits that accumulation of amyloid‑beta plaques is the main cause of AD. New research findings, however... To read more, click here.

Hologram Sciences' personalized nutrition solution must overcome strategic and feature-related factors

Case Study | July 14, 2021

DSM‑backed personalized nutrition company Hologram Sciences launched D.velop, a personalized vitamin D solution to help users build resilient immune health. As a direct‑to‑consumer (DTC) product, the D.velop solution consists of three elements: nutrition pills made of a special form of vitamin D ... Not part of subscription

Concerns about "overdiagnosis" of breast cancer using AI are unfounded and miss the point

News Commentary | September 15, 2021

The use of AI in medical imaging for the diagnosis of breast cancer is seeing widespread adoption. Companies like Google and PathAI have shown impressive progress in detecting breast cancer, with high accuracy and low false positive rates. Concerns of "overdiagnosis" seem unfounded. While it is ... Not part of subscription